Menopause
Commentary
To prevent fractures, treating only women with osteoporosis is not enough
In older osteopenic women, intravenous zoledronic acid effectively prevents fragility fractures.
Clinical Review
2018 Update on bone health
More than one-quarter of women with a hip fracture will be dead within 12 months; maintaining and protecting bone health postmenopause is...
From the Journals
Healthier lifestyle in midlife women reduces subclinical carotid atherosclerosis
Menopausal women who choose a healthier lifestyle – particularly not smoking – have less subclinical carotid atherosclerosis.
From the Journals
Intimate partner violence and PTSD increase menopausal symptom risk
Women who have PTSD related to experiencing intimate partner violence and sexual assault are more likely to experience menopausal symptoms.
Conference Coverage
Estetrol safely limited menopause symptoms in a phase 2b study
E4 has “a remarkably safe profile,” which Dr. Wulf H. Utian describes as “the first natural oral estrogen with the safety profile of a transdermal...
Clinical Review
Low sexual desire: Appropriate use of testosterone in menopausal women
Low-dose testosterone treatment may be considered for HSDD in carefully selected menopausal women after standard therapies have been tried but...
News
FDA okays serum AMH assay to determine menopause status
The new assay is meant to be used in conjunction with a full clinical and laboratory assessment.
Expert Commentary
New and promising GSM treatments, more clinical takeaways from NAMS 2018
Dr. Richard-Davis served as the Scientific Program Chair of the 2018 NAMS Meeting. In this audiocast she highlights several clinical takeaways...
Conference Coverage
No signal for CV, breast effects with bioidentical vaginal estrogen for dyspareunia
Low-dose vaginal softgel is approved for treating moderate to severe dyspareunia associated with menopause.
Conference Coverage
With more mindfulness, menopausal symptoms wane
Women in midlife with the most stress had the most benefit from mindfulness.
Conference Coverage
For dyspareunia, intravaginal prasterone may work best soon after menopause
Age and previous hormone replacement therapy did not influence prasterone’s efficacy in treating dyspareunia.